Robyn M Hunter's most recent trade in Tenax Therapeutics Inc was a trade of 100,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 10, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Tenax Therapeutics Inc | Robyn M Hunter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
Fortress Biotech Inc | Robyn M Hunter | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.38 per share. | 22 Sep 2020 | 28,450 | 192,169 (0%) | 0% | 4.4 | 124,611 | Common Stock, par value $0.001 |